
Experience
Vision Government Solutions Completes Recapitalization With Great Hill Partners
May 6, 2025
Cooley advised Vision Government Solutions, a portfolio company of Rubicon Technology Partners and a leader in the appraisal, computer-assisted mass appraisal and property tax industry, on its majority recapitalization with Great Hill Partners.
Related contacts
Related Practices & Industries
Battery Ventures-Backed PageUp To Be Acquired by EQT Partners
October 31, 2024
Cooley advised Battery Ventures, a global, technology-focused investment firm, and PageUp Group, a human resources and talent software company that had been majority owned by Battery, on the sale of PageUp to EQT Group.
Related contacts
Related Practices & Industries
BlackSignal Technologies Announces $200 Million Sale to Parsons
July 30, 2024
Cooley advised BlackSignal Technologies, a digital signal processing and electronic warfare company delivering advanced processing capabilities in support of national security, on its definitive agreement to be acquired by Parsons Corporation in an accretive deal valued at $200 million.
Related contacts
Related Practices & Industries
Perceptive Advisors Enters Into Definitive Merger Agreement With Vapotherm
June 17, 2024
Cooley advised Perceptive Advisors, a top healthcare investment firm, and its affiliates, including Perceptive Discovery Fund, on its definitive merger agreement with Vapotherm, a publicly traded developer and manufacturer of advanced respiratory technology based in Exeter, New Hampshire, and listed as VAPO on the over-the-counter quotation exchange (OTCQX).
Related contacts
Related Practices & Industries
CallTower Receives Investment From BV Investment Partners
November 16, 2023
Cooley advised CallTower, an international leader in delivering cloud-based, enterprise-class communications, contact center and collaboration solutions, on its investment from BV Investment Partners.
Related contacts
Related Practices & Industries
Related news and events
Amolyt Pharma Agrees to Be Acquired by AstraZeneca in up to $1.05 Billion Cross-Border Transaction
Admissions and credentials
Colorado